Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
21.32
+0.03 (0.14%)
May 6, 2025, 4:00 PM EDT - Market closed
Tandem Diabetes Care Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Tandem Diabetes Care stock have an average target of 39.8, with a low estimate of 20 and a high estimate of 75. The average target predicts an increase of 86.68% from the current stock price of 21.32.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tandem Diabetes Care stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 8 | 8 | 8 | 6 | 6 | 5 |
| Hold | 3 | 3 | 2 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 15 | 15 | 16 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $58 → $59 | Strong Buy | Maintains | $58 → $59 | +176.74% | May 1, 2025 |
| Stifel | Stifel | Strong Buy Maintains $60 → $31 | Strong Buy | Maintains | $60 → $31 | +45.40% | May 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $22 → $20 | Hold | Maintains | $22 → $20 | -6.19% | May 1, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $36 → $30 | Buy | Maintains | $36 → $30 | +40.71% | May 1, 2025 |
| Baird | Baird | Hold Maintains $33 → $24 | Hold | Maintains | $33 → $24 | +12.57% | May 1, 2025 |
Financial Forecast
Revenue This Year
1.02B
from 940.20M
Increased by 8.49%
Revenue Next Year
1.13B
from 1.02B
Increased by 10.78%
EPS This Year
-1.27
from -1.47
EPS Next Year
-0.71
from -1.27
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.1B | 1.2B | 1.3B | ||
| Avg | 1.0B | 1.1B | 1.2B | ||
| Low | 965.7M | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.4% | 18.6% | 17.9% | ||
| Avg | 8.5% | 10.8% | 9.5% | ||
| Low | 2.7% | 3.8% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.06 | -0.45 | 0.92 | ||
| Avg | -1.27 | -0.71 | -0.21 | ||
| Low | -1.41 | -0.97 | -0.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.